Cool Items!🥰New Gadgets Smart Appliances Kitchen Tools Utensils Home ... https://t.co/IS45Zr2rAn via @YouTunmmmjvfcczDllpluouih. Bj
zhu nem za. H ng és. !5!09.ª&755& b mm cv🥳❤️👩🏽🎨😍🙂😌❤️❤️❤️
👉 10th EULAR Live Course on Epidemiology 2023
In this course you will gain an understanding of epidemiology.
📍 Amsterdam
Scientific organiser:
@sofiaramiro82
@LGossec
@pedro_smachado
Register now! 👉 https://t.co/swg0ncTGDp
#EULAR#eularEDUCATION#rheumatology
Looking for a possibility to improve skills in clinical research? Interested in axSpA? Don't miss the opportunity to join our enthusiastic and active SpA team in Leiden with this PhD position:
https://t.co/rUPAwnGMkX
Feel free to disseminate this. Speaking Dutch required.
Looking for a possibility to improve skills in clinical research? Don't miss the opportunity to apply to join our enthusiastic and active SpA team in Leiden! We have a vacancy for a PhD position:
https://t.co/OMdskQiK7n
Please disseminate.
Speaking Dutch is required
Boerhaave organiseert samen met de @NVR_reuma op 11 oktober, 14 maart en 23 mei nascholingen over #reumatologie. Schrijf je in voor 1 of meerdere edities via: https://t.co/HYJnEaZrDZ
Not all researchers have the opportunity to receive expert advice on their #clinical research projects from experienced researchers. This led us to set up the EULAR #ConsultationService.
Researchers can request the free service here:
https://t.co/gtw2ZEEBBa
#rheum#rheumatic
🎙New podcast! Listen to Dr. @sofiaramiro82 and Prof. Robert Landewé discussing their study about the use of #tocilizumab and glucocorticoids in #COVID19. Interview by @Stiddyo
Podcast here 👉🏻https://t.co/U9yODRHJfV
Paper pdf here 👉🏻https://t.co/aL0CxvGB2i
In patients with #COVID19 cytokine storm: methylprednisolone for 5 days with #Tocilizumab was associated with better respiratory recovery and 65% improvement in mortality (HR: 0.35; 95% CI 0.19 to 0.65) compared to supportive care alone. @sofiaramiro82
https://t.co/8UMHdc1NpR
Immunosuppressive treatment (methylprednisolone and if insufficient response additionally tocilizumab) lead to 65% reduction in mortality in COVID-19 associated Cytokine Storm Syndrome. Proud of our team, CHIC study @ARD_BMJ https://t.co/QQrviVDwCv
👉 See the #EULARPressRelease for a new study that demonstrates a widely available immunosuppressant used for the treatment for RMDs dramatically improves patient outcomes when compared with supportive care only 👏
https://t.co/GFThZxOXn7
Fresh from the @EULAR_Press !!
High- dose #methylprednisolone, followed by #tocilizumab if needed, may accelerate respiratory recovery, lower mortality & reduce the likelihood of mech ventilation in #COVID19 - associated #cytokinestorm syndrome!https://t.co/fjQe2H9pi1 @ARD_BMJ
You want to find your "scientific soulmate". The EULAR Immunology course is made for you! Apply now! More details:
https://t.co/qacnqN2VZ3
#Immunologyspeeddating